Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Malaysian Drug Makers See Sales Passing $1 Billion By Year's End

This article was originally published in PharmAsia News

Executive Summary

Malaysia's pharmaceutical industry is expected to pass the $1 billion market by the end of this year, up 10 percent from 2008. Sales are projected at $1.1 billion, thanks primarily to the threatening H1N1 flu pandemic driving higher demand for drugs. Malaysia's drug makers also were less affected by the global economic crisis than were other industries. Jimmy Piong, president of the Malaysian Organization of Pharmaceutical Industries, said the rise in demand for H1N1 medicines offset declining sales of over-the-counter drugs at the same time sales of prescription drugs remained steady, with generics accounting for 35 percent of the Malaysian market. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts